Skip to content
MARKETS / NYSE / DOCS
NYSE · SERVICES-COMPUTER PROGRAMMING SERVICES · LARGE CAP

Doximity, Inc. DOCS

7 fiscal years on record · USD · FY2025 reported · SEC filings only
$644.9M
▲ 13.1% YoY
$196.1M
▼ 12.2% YoY
$326.5M
▲ 19.5% YoY
In brief

What this company does

Doximity, Inc. provides members with AI-powered tools built for medicine, enabling them to collaborate with colleagues, stay up to date with medical news and research, manage their careers and on-call schedules, and conduct virtual patient visits. As of March 31, 2026, it had over 3 million registered members, representing more than 85% of U.S. physicians, spanning all 50 states and every medical specialty, along with two-thirds of U.S. nurse practitioners and physician assistants, and approximately 90% of graduating U.S. medical students. As of March 31, 2026, it had a total of 880 full-time equivalent employees, more than a third of whom work in research and development, including in product, engineering, and data. Its business model drives value for customers through its Marketing, Hiring, and Workflow Solutions. Its Marketing Solutions enable pharmaceutical and health system customers to deliver content, services, and peer connections to medical professionals through a variety of modules. Its Hiring Solutions provide digital recruiting capabilities to health systems and medical recruiting firms, enabling them to identify, connect with, and hire from its network of active and passive medical professional candidates. Its Workflow Solutions, which include telehealth, on-call scheduling, digital fax and AI tools, streamline clinical workflow, reduce administrative burden, connect clinicians with patients and colleagues, and provide evidence-based answers to clinical questions, including drug information. It was incorporated in the state of Delaware in April 2010 as 3MD Communications, Inc., and changed its name to Doximity, Inc. in June 2010.

Written from the business description in Doximity, Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 19 May 2026. Every sentence was checked against that document before publication.

Growth
USD 644.9M
Revenue, FY2025 · full 7-year series below
Revenue $M Net income $M
FY2025 · Revenue 644.9 · Net income 196.1
250.0M500.0M2019202020212022202320242025
Compound annual growth
+15.5%
+25.5%
+20.2%
+31.3%
+22.7%
+71.7%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +25.5% a year over five years — but profit grew faster: net income at +31.3%.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability
30 cents
of every revenue dollar became profit
Operating margin Net margin
FY2025 · Operating 33.3% · Net 30.4%
20%40%2019202020212022202320242025
ROE
FY2025 · ROE 19.3%
1000%2000%2019202020212022202320242025

Each USD of equity produced 19 cents of profit this year.

Cash & shareholders
USD 431.7M
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF 326.5
200M2019202020212022202320242025
Net buybacks $M Dividends $M
FY2025 · Dividends — · Net buybacks 431.7
200M400M2019202020212022202320242025

USD 431.7M in buybacks — 220% of the year's profit, so the payout drew on cash built up earlier.

Total assetsUSD 1.1B
EquityUSD 950.8M
CashUSD 219.2M
Current ratio6.09×

Equity funds 85% of total assets.

The 7-year record
7 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative
Metric 2025202420232022202120202019
Revenue $B0.60.60.50.40.30.20.1
Operating income $B0.20.20.20.10.10.10.0
EBITDA $B0.20.20.20.10.10.10.0
Income tax $B0.10.00.00.0−0.00.0−0.0
Net income $B0.20.20.10.10.20.10.0
Free cash flow $B0.30.30.20.20.10.10.0
EPS, diluted $0.981.110.720.530.700.230.13
Dividend / sh $·······
Payout %·······
ROE %19.322.515.812.232.7147.92617.7
Shares out B0.180.190.190.190.190.08·

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Compare

This company against its peers

Provenance
Company facts, as filed
How we verify · 0 failures in 33 reconciliationsAUDITED

Reconciled in 7 of 19 fiscal years. 62 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityServices-Computer Programming Services
Listed onNYSE
Incorporated inDelaware
Fiscal year endsMarch 31
Data on record since2019

Share this section

Download image